What TMRW Life Sciences does

TMRW Life Sciences is a New York-based fertility technology company that has built the world's first FDA-cleared automated platform for the safe management of frozen eggs, embryos, and sperm. The platform combines proprietary hardware — the CryoRobot Select automated high-volume storage system, the TMRW Vault manual liquid tank, and the TMRW Biorepository offsite storage facilities — with a software stack that includes the RFID-enabled CryoBeacon tracking system, the HIPAA-compliant ivfOS cloud-based management platform that integrates with clinic EMR systems, the CryoLink digital workstation, and the Overwatch 24/7 environmental monitoring service. Together these components deliver a complete digital chain of custody for each specimen, reducing the manual error risk inherent in traditional dewar-based storage.

The company sells primarily to enterprise fertility clinics and IVF centers in the United States through a direct enterprise field-sales motion, with contract structures combining hardware sales, reformatting/onboarding services, and recurring subscription fees for software, monitoring, and storage. Named customers include CCRM Fertility, Pinnacle Fertility, IVIRMA North America, and Reproductive Fertility Center (RFC). The platform is marketed on quantifiable operational outcomes — including a 94% reduction in potential points of failure, 87% lab workflow optimization, and 70% space savings versus traditional dewars — and is supported by FDA clearance, CE marking, and HIPAA-compliant military-grade data security. In April 2026, TMRW announced a strategic business combination with Reprotech, under which the combined company will operate under the Reprotech brand, with stated intent to better serve fertility clinics across the US and pursue international expansion.

Name

TMRW Life Sciences

Legal name

TMRW Life Sciences, Inc.

Website

https://tmrw.org

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

51–100 employees

Short description

TMRW Life Sciences provides the world's first FDA-cleared automated cryostorage platform — combining robotic storage, RFID tracking, and cloud-based specimen management software — for fertility clinics and IVF centers managing frozen eggs, embryos, and sperm.

Ownership category

akta.pro rank

Product category

Fertility Cryostorage Technology

NAICS

Other Measuring and Controlling Device Manufacturing (334519), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512)

SIC

Refrigeration & Service Industry Machinery (3580)

akta.pro primary industry

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)

akta.pro secondary industries

Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)

Keywords

• Automated cryostorage systems
• Fertility specimen management
• IVF lab automation
• Embryo storage technology
• Digital chain of custody

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Cryostorage Platform Subscription: TMRW provides automated storage solutions to fertility clinics through subscription-based arrangements for their platform technology, monitoring services (Overwatch), and storage solutions (CryoRobot, Vault, Biorepository). The model includes on-site and offsite storage options with recurring service fees.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

TMRW Life Sciences provides the world's first and only FDA-cleared automated platform for safe management of frozen eggs, embryos, and sperm at fertility clinics. The integrated platform combines automated robotic storage hardware (CryoRobot Select), manual liquid storage tanks (TMRW Vault), offsite biorepository services, and HIPAA-compliant cloud-based specimen management software (ivfOS) with RFID-enabled digital chain-of-custody tracking and 24/7 environmental monitoring (Overwatch).

Product overview

TMRW Life Sciences offers a unified platform combining automated storage hardware with digital specimen management software. The core TMRW Platform/CryoRobot Select provides automated high-volume specimen storage, while the TMRW Vault offers manual storage alternatives. These hardware systems are supported by software products including ivfOS (cloud-based EMR-integrated management platform), Overwatch® (advanced monitoring system), CryoLink (digital workstation), CryoBeacon (RFID tracking system), and CryoLink (connectivity layer), all tied together through the digital chain of custody architecture. The TMRW Biorepository provides offsite storage facilities. Optional reformatting services enable seamless clinic onboarding. The company was formed through a 2026 merger with Reprotech.

Differentiator

Problem solved

Functional benefit

Products and services

• TMRW Platform

Quantifiable outcome

• 94% reduction in potential points of failure
• +2 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• Pinnacle FertilitycoreStrategic or Co-development Partner · 17 April 2026Pinnacle Fertility collaborated with TMRW Life Sciences as part of the egg freezing and embryo banking market expansion. The partnership leverages TMRW's automated cryostorage technology within Pinnacle's fertility clinic network, with clinic leadership actively involved in guiding product development and improvement.
• ReprotechflagshipStrategic or Co-development Partner · 2 April 2026Reprotech and TMRW Life Sciences announced a strategic business combination to create the most comprehensive technology-enabled cryostorage company in fertility. The merger combines Reprotech's long-term cryostorage experience with TMRW's digital and automation technology, creating a combined company operating under the Reprotech brand to better serve fertility clinics across the US with potential international expansion.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Reprotech: Long-term cryostorage company for reproductive specimens that is entering a strategic business combination with TMRW in April 2026. Direct overlap in fertility specimen storage services, with TMRW contributing digital/automation and Reprotech contributing long-term storage customer base.
• Genea Biomedx: Develops instruments, consumables, and software for IVF labs including time-lapse incubators and lab workflow technology. Comparable as a technology-led vendor serving embryologists and IVF centers with workflow and automation products.
• Cryoport, Inc. Provides temperature-controlled cold-chain logistics and cryogenic storage solutions for life sciences, including reproductive medicine. Comparable as a cryogenic logistics and storage services provider to high-value biological specimens.
• Vitrolife AB: Global IVF/ART technology and device company offering lab equipment, media, and consumables for fertility clinics. Comparable as a full-stack vendor of ART lab technology addressing similar embryologist and clinic customers.
• Hamilton Storage (Hamilton Company): Manufactures automated sample storage systems and biobanking platforms (e.g., BiOS, SAM). Comparable as a supplier of automated cryogenic storage and sample management infrastructure to life science and clinical customers.
• BioLife Solutions, Inc. Supplier of biopreservation media, cryogenic storage, and cold-chain products for cell and gene therapy and reproductive cells. Comparable as a developer of cryopreservation/conservation tools for high-value biological specimens.

Broad incumbents

• CooperSurgical: Large women's health and fertility medical device company offering ART/IVF devices, consumables, and lab equipment. Comparable as a broad incumbent serving the same fertility clinic channel with overlapping lab technology products.
• Azenta Life Sciences (formerly Brooks Life Sciences): Provider of automated sample storage, biobanking, and cold-chain solutions for pharma, research, and clinical customers. Comparable as a broad incumbent in automated cold storage and sample management infrastructure.
• Chart Industries, Inc. Global manufacturer of cryogenic equipment, LN2 storage tanks, and cold-chain solutions serving life sciences, medical, and industrial customers. Comparable as an established cryogenic hardware manufacturer with overlapping distribution into life-science storage.

Emerging players

• Planer plc: UK-based specialist in controlled-rate freezers and cryogenic storage equipment used in IVF, cell therapy, and biobanking. Comparable as a niche/emerging vendor of cryopreservation equipment serving fertility and life-science customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/tmrwlifesci
• Facebookfacebook.com/TMRWLifeSciences
• LinkedInlinkedin.com/company/tmrw-life-sciences-inc
• Instagraminstagram.com/tmrwlifesciences
• TikToktiktok.com/@tmrwlifesciences

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TMRW Life Sciences